Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
BACKGROUND: It is expected that a steady increase in the incidence of diabetes and resistant hypertension (RHTN), along with an increase in life expectancy, will lead to a noticeable increase in the proportion of patients with heart failure with preserved ejection fraction (HFpEF). At the same time,...
Guardado en:
Autores principales: | M. A. Manukyan, A. Y. Falkovskaya, V. F. Mordovin, T. R. Ryabova, I. V. Zyubanova, A. M. Gusakova, T. E. Suslova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fb8119cadec435b8a738bda324cfa57 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva O, et al.
Publicado: (2020) -
A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021) -
Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Steffen Pabel, et al.
Publicado: (2021) -
Faltering Under Pressure: Limitations to Noninvasive Diastolic Function Assessments
por: James P. MacNamara, et al.
Publicado: (2021) -
Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: Arno A. van de Bovenkamp, et al.
Publicado: (2021)